Answers are grounded in this paper and cite their sources.
Supplemental Table 2 shows the distribution of presence/absence of percentage of the marker in the tumor, by age of sample for type I and type II tumors
No takes yet. Share an insight, caveat, or question.
Hathaway et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: